Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy [NA]
This completed clinical trial compared oral brivaracetam with levetiracetam as monotherapy for epilepsy and notes completion without present…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy [NA]
A clinical trial studying ADHD rating scales in people with epilepsy has completed.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Focused Ultrasound for Drug-resistant Epilepsy [NA]
A clinical trial investigating MR-guided focused ultrasound for drug-resistant epilepsy is currently recruiting in Taiwan, sponsored by Taip…
-
CLINICAL_TRIALS other · 2025-09-09Clinical Trial Update: Neuronal and Network Mechanisms of Electrocortical Stimulation [NA]
Clinical trial update examining neuronal and network mechanisms of electrocortical stimulation. Enrollment is by invitation at Northwestern …
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Flexible Representation of Speech [NA]
The University of Pittsburgh-conducted trial on flexible representation of speech in epilepsy has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Genetic Markers of Cardiovascular Disease in Epilepsy
A Mayo Clinic-sponsored clinical trial is investigating genetic markers of cardiovascular disease in people with epilepsy. The study is curr…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Cenobamate in Adults With Focal-Onset Seizures
Clinical trial update on cenobamate in adults with focal-onset seizures; the study is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS withdrawal · 2025-09-08Clinical Trial Update: EpiCare@Home Validation Study for Focal Onset Seizures [NA]
A clinical trial evaluating EpiCare@Home for focal onset seizures has been withdrawn.
-
FDA approval · 2025-09-05FDA Approved: GABARONE — Supplemental Application (INA Pharmaceutics Inc.)
FDA approved a supplemental application for GABARONE (gabapentin) by INA Pharmaceutics Inc. under ANDA211313. This action typically reflects…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Epilepsy Involving the Temporal Lobe Region. [NA]
Terminated clinical trial evaluating a 24/7 SubQ EEG system for ultra-long-term recording in epilepsy patients, including temporal lobe invo…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Simultaneous MEG or fMRI And INtracranial EEG [NA]
The clinical trial evaluating simultaneous magnetoencephalography (MEG) or functional MRI with intracranial EEG has completed. The study enr…
-
FDA approval · 2025-09-03FDA Approved: VIGAFYDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for VIGAFYDE (vigabatrin) submitted by Upsher-Smith Laboratories, LLC. The action updates the produc…
-
FDA approval · 2025-09-02FDA Approved: TOPIRAMATE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s original application for a generic topiramate product. This approval makes generic topiramate avai…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Getting SMART for Pediatric Epilepsy [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating a treatment for epilepsy in children has completed and posted results. The study was sponsored by Nati…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Baker Gordon Syndrome Natural History Study
Clinical trial update indicates the Baker Gordon Syndrome Natural History Study is currently recruiting participants, focusing on rare disea…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy
A clinical trial update describes a multimodal PET imaging approach using 18F-FDG, SV2A-targeted radiotracers, and TSPO ligands to aid resec…
-
FDA approval · 2025-08-28FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approves a supplemental application for Briviact (brivaracetam) from UCB, Inc., resulting in labeling updates for the product.
-
FDA approval · 2025-08-28FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment [Phase 3]
Phase 3 study evaluating the long-term safety and tolerability of oral lacosamide in pediatric epilepsy patients who completed prior lacosam…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Mapping of Human Cognition [NA]
Clinical trial update for a study titled Mapping of Human Cognition, sponsored by The University of Texas Health Science Center, Houston, is…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Children's Adaptive Deep Brain Stimulation for Epilepsy Trial (CADET): Pilot [NA]
The CADET pilot trial evaluating adaptive deep brain stimulation for pediatric epilepsy has completed, with no outcome data provided in the …
-
EMA approval · 2025-08-27EMA Authorised: Pregabalin Accord (pregabalin) — Accord Healthcare S.L.U.
The EMA authorised the generic pregabalin product Pregabalin Accord for anxiety disorders and epilepsy.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Idiopathic Generalized Epilepsy Syndromes
This entry notes that a clinical trial focused on idiopathic generalized epilepsy syndromes is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology
A clinical trial is evaluating how common neural autoantibodies are in people with new-onset focal seizures of unknown etiology, and it is c…
-
FDA approval · 2025-08-26FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
The FDA approved a supplemental application for Gabapentin from Granules Pharmaceuticals Inc. This approval updates the product's labeling/i…